Particulate matter less than 2.5 m in diameter linked to higher sudden cardiac death risk in women
SAD cause of considerable proportion of deaths in CHD patients without severe systolic dysfunction
Findings show MHO is transient, so not a reliable predictor of lower cardiovascular risk in the future
Aortic distensibility independently linked to concentric left ventricular remodeling
FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization.
Increased risk of CVD for achieved systolic blood pressure of 120 versus 130 or 140 mm Hg
Older patients who had more frequent nephrology visits prior to initiating dialysis had a lower incidence of atrial fibrillation in the year after initiating dialysis compared with those who did not.
Benefit of exercise against cardiovascular disease notable even among those at high genetic risk
Social isolation linked to increased mortality among individuals with history of AMI or stroke
Environmental lead exposure tied to all-cause, cardiovascular disease, ischemic heart disease mortality.
But no mortality risk reduction associated with weight loss in individuals with coronary heart disease
Clopidogrel noninferior for patients older than 65 years after acute coronary syndrome hospitalization.
After adjustment for hormone therapy use in women, associations no longer differed by sex
All-cause and cardiovascular mortality risks were 22% and 34% higher among febuxostat-treated patients vs allopurinol recipients.
Individuals who had a stroke or transient ischemic attack at age 60 to 64 had a 2-fold higher risk of UUI at age 68 years, a British study found.
Cardiac MR accurately diagnoses; myocardial scars may affect 8% of women with non-obstructive CAD
In a study, the 30-day readmission rate for hemodialysis patients hospitalized for cardiovascular events was 34.2%.
A large study of middle-aged men found that testosterone replacement therapy is associated with a small but significant decrease in cardiovascular risk and an increased risk of obstructive sleep apnea.
Vitamin D levels increased from 13.2 to 33.7 ng/mL in nondialysis CKD patients treated with 50,000 units of cholecalciferol weekly for 12 weeks.
Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease
No association with ICH; within HDL, cholesterol inversely and triglyceride positively linked to MI
Study questions the efficacy and safety of prescribing anticoagulants to older patients with atrial fibrillation and nondialysis chronic kidney disease.
Abnormal calcium-phosphate metabolism appears to be an important pathogenic factor in the development of vascular calcification in patients with chronic kidney disease.
44% drop in stroke for those with intermediate CVD risk receiving candesartan/HCTZ, rosuvastatin
Risk scores summarizing 8 diseases, markers tied to cancer risk in dose-response manner
No significant association with fatal, nonfatal coronary heart disease, major vascular events
Study finds no difference in all-cause mortality among patients with chronic kidney disease and heart failure who received implantable cardioverter defibrillators and those who did not.
In hemodialysis patients, only non-traditional risk factors such as C-reactive protein predicted non-fatal myocardial infarction and other atherosclerotic events, researchers report.
High levels of worry in Mexican-origin women studied tied to risk of higher BMI, obesity, blood pressure.
No patient had a 25% or greater rise in serum creatinine 48 hours after receiving a median 13 mL of contrast for diagnostic coronary angiography, with an additional 13 mL for percutaneous coronary intervention.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)